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1. Introduction 
H. A. Krebs has pointed out the importance to 
metabolic regulation of certain small inorganic ions 
which are not normally thought of as metabolites. 
The compounds discussed were CO*, HCOS, H’, NH: 
and Pi [ 11. It has been appreciated subsequently that 
Mg*+, while not subject to large intracellular variations 
under most physiological conditions, [2] has appre- 
ciable effects on the apparent equilibrium constants of 
a number of important intracellular reactions [3,4] 
and should be included in this list. In this paper we 
attempt to show that inorganic pyrophosphate (PPi) 
is another small inorganic ion which plays an impor- 
tant role in the regulation of a number of metabolic 
processes in mammals as a result of hormonal or 
dietary changes. 
Pyrophosphate has long been known to play an 
important role in intermediary metabolism ln some 
microorganisms [5] and in Entamoeba histolytica [6], 
where it acts in place of ATP as an energy source in 
the phosphorylation of fructose 6-phosphate and ln 
other key reactions of the glycolytic and gluconeogenic 
pathways. Pyrophosphate has been shown to be the 
product of photophosphorylation in Rhodospirillum 
rubrum [7] and may play a role ln mammalian oxi- 
dative phosphorylation [8]. This view has not been 
generally accepted because of the widespread, but in 
our view erroneous, belief that pyrophosphate is rap- 
idly hydrolyzed in cells to inorganic orthophosphate. 
In data not presented here, we have shown that under 
appropriate conditions, injection of short chain fatty 
acids can raise hepatic PPi content to 2-3 pmol/g 
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wet wt. If the bulk of the pyrophosphate were con- 
fined to mitochondrial matrix where it is generated 
during short chain fatty acid activation, and if PP, 
were all in free solution in the matrix, the mitochon- 
drial [PPi] would be >20 mM. 
It has long puzzled pharmacologists that some of 
the effects of dibutyryl cyclic AMP can be mimicked 
by butyrate alone [9]. Certain abnormalities of trans- 
formed cells in culture can be returned toward normal 
by addition of butyrate to cell cultures, which raises 
the possibility that butyrate affects the acetylation 
reactions of nuclear histones. Our fmdings suggest 
that pyrophosphate, either directly administered or 
produced intramitochondrially by activation of short 
chain fatty acids, produces effects which mimic glu- 
cagon injection in that the free cytoplasmic [NADP+]/ 
[NADPH] is decreased, liver glucose is increased, 
ketone body concentrations are increased and there is 
a change in 3-phosphoglycerate/pyruvate ratios sug- 
gestive of inhibition of pyruvate kinase [ 111. Since 
glucagon injection produces CAMP at levels of 8 nmol/g 
and should therefore produce PPi in equal amounts, 
distinguishing CAMP effects from PPi effects after 
glucagon stimulation will be difficult, particularly in 
view of the likely reciprocal relationship between free 
[Ca”‘] and free [PPi] because of the extreme insolu- 
bility of CazPPi. 
In addition to the effects of PPi on glucose metab- 
olism, the finding of relatively high cellular contents 
of PP, raises the possibility that reactions of nucleic 
acid or protein synthesis might be affected. The reac- 
tions catalysed by the various DNA polymerases are 
of the form: 
Mg*+ 
Desoxy-XTP + (desoxy-XMP),, Z$ (Desoxy-XMP), + 1 + PPi 
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These reactions are known to be reversible in the pres- 
ence of PPi [ 121. The widely held view that PPi is 
instantly hydrolyzed to ensure the inviolability of 
DNA needs reconsideration. Whether the concentra- 
tions of pyrophosphate achieved in this study are 
high enough to inhibit or reverse the reactions of 
DNA or RNA polymerases remains to be seen. It may, 
however, be significant that freshly isolated hepato- 
cytes treated with 5-7 mM butyrate are reported to 
show decreased incorporation of [3H]orotic acid into 
RNA without increasing [3H] acetate incorporation 
into nuclear histones [131. 
2. Experimental 
Male Wistar ats (180-230 g body wt) were pur- 
chased from Charles River Labs. (Wilmington, MA) 
and received food (NIH stock diet) and water ad libi- 
turn. All animals were killed in the morning and 
stomach contents were checked to be certain that all 
animals were well fed. 
Butyric acid and oleic acid were purchased from 
Sigma Chemical Co. (St Louis, MO). Sodium acetate 
was purchased from J. T. Baker Chemical Co. 
(Phillipsburg, NJ). Commercially available nzymes 
were obtained from Boehringer-Man-nheim 
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(Indianapolis, IN). The pyrophosphate-fructose 
6-phosphate-phosphotransferase for PPi assays was a 
gift of Dr W. E. O’Brien, Baylor College of Medicine 
(Houston, TX). All other materials were reagent grade 
and obtained from commercial sources. 
Rats were injected intraperitoneally with glucose 
(20 mmol/kg), sodium phosphate (20 mmol/kg), NaCl 
(20 mmol/kg), sodium acetate (20 mmol/kg), sodium 
butyrate (20 mmol/kg), sodium oleate (3 mmol/kg) 
or physiological saline (2 ml) 15 min before killing. 
Sodium pyrophosphate (1 mmol/kg) was injected 
20 min before killing. All solutions were adjusted to 
pH 7.0. 
Rats were killed by cervical dislocation and livers 
were rapidly removed and frozen by clamping between 
two aluminium discs which had been cooled in liquid 
nitrogen [ 141. Perchloric acid extracts of frozen liver 
were prepared as in [ 15 ] except hat the extracts were 
not treated with Florisil; the extracts were adjusted 
to pH 5-6 rather than pH 7 in order to increase the 
recovery of PPi [ 16 1. 
PPi was measured by the method of Cook et al. 
[ 161. Inorganic orthophosphate was measured using a 
modification [171 of the method of Guynn et al. 
[ 181. Lactate, malate, glucose 6-phosphate, glucose 
l-phosphate, isocitrate and ATP were measured as 
described by Lowry and Passomreau [ 191. ADP and 
Table 1 
Values of equilibrium constants 
Definition Value Ref. 
KLDH 
[ Zpyruvate] [ NADH] 
= 
[ Zlactate] [NAD+] 
= 1.11 x 10-a v91 
KfCDH 
[Zo-ketoglutarate] [CO, ] [ NADPH] 
= 
[ Cisocitrate ][ NADP+] 
= 1.17M ]341 
KHBDH 
[ Zacetoacetate] [ NADH] 
= 
[ BP-hydroxybutyrate] [ NAD+] 
= 4.93 x lo-* 1291 
KG + GKLDH 
[Z3PG] [ZATP] [ Xlactate] 
= 
[ ZDHAP]/22 [ XADP] [ CPi] [ Xpyruvate] 
= 1.65 X 10’ M-’ 141 
KMyR at pH 7.2 
[ XATP] [ ZAMP] = 
[ ZADP]= 
= 1.12 [41 
Kppi-Glucose 
phosphotransferase = 
[ ZglUCOsed-P] [ XPi] 
= 45.9 
[ Xglucose] [ ZPPi] 
]201 
KUD~G PPiase 
[WTP] [Xglucose-l-P] = = 4.55 
[ ~UDP-glucose] [CPPL] 
[35] 
Values are given at an ionic strength = 0.25, + = 38°C free [Mg’+] = 1.0 mM and pH 7.0 [CO,] was taken to be 1 .I6 mM 
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AMP were assayed as described by Adam [20] except 
that Tris buffer was used instead of TEA. All other 
metabolites were assayed as described in [2 11. 
Free cytosolic [PPi], mitochondrial free [NAD’] / 
[NADH], cytosolic free [NADP’] / [NAJIPH] and 
cytosolic free [NAD’] / [NADH] were calculated as in 
[21]. Free cytosolic [L7ATP]/[LADP] [ZPi] ratios, 
free cytosolic [LADPI and myokinase ratios were 
calculated as described by Veech et al. [4]. Equilib- 
rium constants of relevant reactions are given in table 1. 
3. Results and discussion 
There is no significant gradient of glucose concentra- 
tion across the liver plasma membrane; therefore the 
concentration of blood glucose approximately reflects 
that of liver glucose. While increase of glucose 6-phos- 
phate concentration isinevitably accompanied by 
increases in glucose l-phosphate and fructose 6-phos- 
phate, because of the near-equilibrium reactions cata- 
lysed by glucosephosphate isomerase and phosphoglu- 
comutase, there is no constant relationship between 
glucose and glucose 6-phosphate. As the data in table 2 
indicate, there is a general correlation between the con- 
tent of glucose and that of glucose 6-phosphate, but 
there are notable exceptions to this. For example, 1 h 
after injection of bovine growth hormone there is a 
2-fold rise in glucose 6-phosphate concentration and a 
fall in that of glucose [111. Following induction of 
streptozotocin diabetes there is a 3.fold increase in 
liver glucose level accompanied by a 50% decrease in 
liver glucose 6-phosphate [21]. 
Many reactions contribute to the establishment of 
the steady state concentration of glucose 6-phosphate, 
which can be produced from glycogen via phosphoryl- 
Table 2 
Metabolite content of freeze-clamped rat liver 
II’ 
COlltrOl Phosphate Pyrophosphate Glucose NaCl Acetate Butyrate 0leate 
(20 mmollkg) (1 mmol/kK) (20 mmol/kg) (20 mmol/kK) (20 mmol/kg) (20 mmol/kg) (3 mmol/kg) 
16 6 6 6 6 6 5 6 
GlUCOSe 7.30 11.1 
5.16 $3 
Glucose 6-P 0.121 
to.007 
0.693 
+0.039 
Glucose 1-P 0.010 
ffl.0004 - 
Dihydroxy- 0.029 
acetone-P +o. 001 
3-Phosphoglycerate 0.309 
$013 
0.053 
+0.004 
0.041 
+0.003 
0.673 
+0.043 
Pyruvate 
Lactate 
a-Ketoglutarste 
1socitrate 
Glutamate 
Malate 
Acetoacetate 
t3-Hydroxy- 
butyrate 
0.086 0.219 
5.009 +0.013 
0.444 
+0.031 - 
0.279 
3.019 
0.030 
+0.002 
3.91 
+0.40 - 
0.124 
+0.018 - 
0.065 
.+o. 003 
3.86 2.31 
+0.12 3.11 
0.274 
+0.015 
0.691 
+0.030 
0.117 
+0.009 - 
0.156 
+0.015 - 
0.092 
+o.ooa - 
0.274 
5.025 
15.7 75.9 
+0.7 +1.4 - - 
0.418 0.429 
+0.033 +0.049 
0.032 0.023 
+0.001 +0.002 
0.038 0.098 
+0.002 +O. 006 
0.850 0.409 
+0.021 +0.024 - - 
0.095 0.372 
+0.008 +0.034 - - 
0.685 2.74 
+o. 109 +o. 18 - - 
0.095 0.169 
+0.013 +0.006 - - 
0.017 0.029 
+o.OOl +0.022 
2.27 1.57 
20.14 +0.44 
0.210 0.362 
+0.014 +0.020 - 
0.195 0.088 
9.014 +o. 009 - 
0.302 0.217 
s.025 +0.009 
7.93 
+o. 37 - 
0.175 
ffl.005 - 
0.011 
ffl.001 - 
0.051 
+0.005 - 
0.369 
+0.031 - 
0.165 
+0.025 
0.812 
+O.llO 
0.276 
+0.021 
0.039 
+0.002 - 
3.15 
+0.10 
0.401 
+o.oxl - 
0.123 
+0.015 
0.225 
+0.057 
12.4 
+0.2 - 
0.604 
+0.055 - 
0.045 
+o.oos 
0.028 
+o. 003 - 
0.556 
+0.027 
0.069 
+0.013 
0.657 
+0.009 - 
0.134 
+0.026 
0.055 
+0.004 
2.27 
+0.15 - 
0.845 
+0.095 - 
0.107 
+0.021 - 
0.266 
+0.015 
15.68 
5.54 
0.777 
+0.023 
0.055 
+0.002 - 
0.039 
+0.003 
0.501 
+O. 023 
0.067 
+o. 005 - 
0.925 
+O. 124 - 
0.072 
+0.000 - 
0.049 
3.002 
11.0 
+o. 4 - 
0.421 
+0.021 - 
0.026 
+0.002 - 
0.048 
+0.002 - 
0.523 
+0.050 - 
0.133 
+0.011 
0.765 
20.060 
0.179 
3.022 
0.021 
+0.002 
1.87 __ 
+0.16 __ 
1.27 
+0.17 
0.793 
+0.06 - 
1.66 
+0.10 - 
0.223 
+0.025 - 
0.173 
+0.007 
0.137 
+0.011 - 
Values are in rmol/g wet wt liver + SEM 
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ase and phosphoglucomutase, or from glucose via glu- 
cokinase. It can be dispersed via glycogen synthase, 
glucose l-phosphate uridylyltransferase and phospho- 
glucomutase, orvia glucose 6.phosphate dehydrogen- 
ase and the hexose monophosphate pathway, or via 
glucose phosphate isomerase, phosphofructokinase 
and the glycolytic pathway. Finallv, glucose 6.phos- 
phate may leave the liver as glucose, as a result of the 
action of glucose 6.phosphatase. With the exception 
of the reactions catalyzed by glucosephosphate iso- 
merase and phosphoglucomutase, theproducts of 
which are in near-equilibrium with glucose 6-phos- 
phate, all the other reactions accounting for the for- 
mation or utilization of glucose B-phosphate have 
generally been thought o be controlled by regulation 
of enzyme activity, either by allosteric effecters or by 
covalent modification. Under this type of control, no 
constancy of the glucose/glucose 6.phosphate ratio 
would be expected. The data presented in tables 3 
and 4, however, indicate that under most conditions 
studied, a state of near-equilibrium exists in the over- 
all reaction represented as eq. (1). The value of the 
equilibrium constant for this reaction at ionic strength 
0.25, 1 mM free Mg2+ and 38’C is [21]: 
K, = [Glucose 6-phosphate] [Pi] 
’ [Glucose] [free cytopl. PPi] 
= 45.9 (1) 
In control animals, this ratio was 48.5. Fifteen min- 
utes ,after injection of inorganic orthophosphate, the 
observed ratio was 173 indicating that near-equilib- 
rium had not yet been re-established, but that the 
deviation was in the direction expected by increasing 
Pi. In a similar fashion, injection of glucose induced 
the expected isequilibrium where the metabolite 
ratio for eq. (1) was 4.6. Rather surprisingly, injec- 
tion of PP, resulted in only a 4-fold rise in free cyto- 
plasmic pyrophosphate even though total PP, content 
increased loo-fold. It is not possible to determine 
whether the measured PP,, after PPl injection, was in 
the mitochondria or whether a large portion of it 
remained in the extracellular space. In any case, the 
largest proportion of injected PPi appeared to be sep- 
arated from the glucose 1 -phosphate uridylyltransfer- 
ase activity. The value for eq. (1) of 38.2 suggested 
that the pyrophosphate-glucose-phosphotransferase 
reaction was maintained near-equilibrium. Near-equi- 
librium was re-established, after pyrophosphate injec- 
Table 3 
Phosphorylated nucleotides and phosphate content of freeze-clamped rat liver 
II- - 
Control Phosphate Pyrophosphate Glucose NaCl Acetate Butyrate 0leate 
(20 mmollkg) (1 mmol/kg) (20 mmol/kg)(ZO mmollkg) (20 mmol/kg)(ZO mmol/kg) (3 mmol/kg) 
6 6 6 6 6 6 5 6 
ATP 
Measured ADP 
Calculated Free 
CytoplaBmic ADP 
AMP 
Pi 
UTP 
UDPC 
Measured PPi 
Calculated 
Cytoplasmic PPi 
2.72 
to.07 
1.02 
3.03 
2.35 
3.08 
1.39 
3.05 
0.061 0.051 
s.004 +0.005 
0.205 
to.010 
3.45 
5.06 
0.281 
+0.021 - 
0.509 
+0.022 - 
0.0144 
+0.0014 - 
0.0012 
+O. 00006 
0.314 
+0.031 - 
18.24 
+O.Ql - 
0.305 
~0.003 
0.517 
+0.024 
0.0323 
+0.0022 - 
0.0070 
+0.0008 - 
2.82 
+o.O6 
1.16 
+0.04 
2.50 
+0.05 - 
0.98 
20.03 
0.084 
+0.006 - 
0.227 
+0.021 
0.034 
+o. 005 
0.184 
+o.O06 
7.08 3.23 
+0.37 5.11 
0.331 
+0.025 - 
0.471 
+0.023 - 
1.58 
+0.14 - 
0.0050 
+0.0003 - 
0.258 
+0.022 
0.326 
+0.009 - 
0.0145 
+0.0004 - 
0.0039 
+o. 0004 
2.78 
20.08 
0.92 
+0.04 
0.041 
ffl.005 - 
0.129 
+0.011 
3.49 
+0.13 - 
0.149 
+0.023 - 
0.474 
ia. - 
0.0180 
+0.0007 
0.0009 
+0.0001 - 
2.47 
+0.08 - 
1.55 
+o. 03 - 
0.159 
s.028 
1.58 2.68 
+0.07 20.06 
1.47 
20.04 
0.453 
+0.021 
0.075 
+0.012 - 
0.918 
+0.077 
4.45 5.13 
+0.021 +0.24 
0.209 
+0.022 - 
0.495 
+0.016 - 
0.142 
+0.060 - 
0.0042 
+0.0007 
0.240 
20.036 
0.526 
50.016 
0.119 
TO.067 
0.0055 
+0.0008 - 
0.827 
+o. 049 - 
0.072 
+o. 009 
0.139 
20.016 
3.18 
+o. 20 - 
0.333 
+O. 036 - 
0.555 
+0.030 - 
0.0150 
+0.0006 - 
0.0033 
+0.002 - 
Values are given in wmol/g wet wt f SEM 
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25 August 1980 
Free nucleotide ratios in freeze-clamped rat liver 
Cont l-01 Phosphate Pyrophosphate Glucose NaCl Acetate Butyrate 'Olcate 
(20 mmollkg) (1 mol/kg) (20 mmnol/kg) (20 mmollkg)(ZO mmol/kg) (20 mmollkg) (3 mnollkg) 
n- 16 6 6 6 6 6 5 6 
Cyto lasmic 
P [NAD l/[NADHl 
from !$,DH 
Mltochondrial 
tNAD+l/[NADHl 
~~~KBHBDH 
Cytop1amllic 
[NADP+]/[NADPHl 
from KICDH 
Measured 
IATPI/[ADPl[PiI M-l 
Calculated 
[ATPl/[ADPItPil M-l 
from KC + C 
Measured 
IATPIIAMPI 
IABPIL 
3-Phosphoglycerate 
Pyruvate 
1750 
+130 - 
520 1360 
_"O +I80 
1230 
+110 - 
1790 
+160 
950 
+100 - 
700 1600 
+90 +I60 - - 
16 
21 
7 
+1 - 
14 
+2 
a 
+1 
12 
+1 - 
8 
+1 
10 
+2 - 
0.010 0.0019 0.0055 0.0060 
+O.OOl +0.0003 +0.0005 +0.0005 
0.0072 0.0024 
+o.ooog +0.0004 - - 
0.0015 
+0.0002 
795 
+52 - 
14000 
+1200 - 
96 353 
+10 +25 
2700 
+310 - 
5040 
+670 - 
802 
+56 - 
25300 
+3900 - 
899 
+97 
20900 
+2300 
363 
+24 - 
4800 
+1000 - 
214 
+19 
4600 
+700 - 
0.538 
+0.031 
0.375 
+0.012 
0.476 
+0.032 - 
0.484 0.429 0.464 0.663 0.553 
3.024 f3.026 +0.012 +0.023 20.065 
48.5 
+2.9 
3.5 
173 
+20 
3.1 
38.2 4.6 
+3.3 +0.3 - - 
8.9 1.1 
96.3 
+19 - 
2.2 
55.7 
+6.3 
8.1 
50.8 
+0.4 
7.4 
26 
+2 
0.0087 
+0.0009 
1076 
+125 
13000 
+I800 
37.3 
23.2 
3.9 
For method of calculation see text and table 1 
tion by: (i) doubling the liver glucose; (ii) doubling 
the liver Pi; (iii) increasing lucose 6-phosphate by 
4-fold; (iv) increasing the free cytoplasmic pyrophos- 
phate 4-fold. The enzymic pathway catalyzing this 
near-equilibrium reaction cannot be defined at present; 
however, such a relationship does occur in vivo. 
Changes in free cytoplasmic PPi concentration cannot, 
therefore, be ignored in considering the control of 
liver and blood glucose levels, nor in considering the 
mode of action of hormones which affect blood glu- 
cose concentrations. 
Interest in control of liver glucose levels has gener- 
aIly focused on the control of either the glucokinase 
reaction [22] or the reactions of glycogen synthesis 
and breakdown [23]. The importance of free cyto- 
plasmic [~PPi] in controlling liver glucose and, hence, 
blood glucose levels has not been generally recognized. 
Nevertheless, the effects of free cytoplasmic [ZPPl] 
upon liver glucose levels can be demonstrated, without 
injecting PPi, by taking advantage of the ability of 
cells metabolizing various chain length fatty acids to 
perturb PPi levels in the cytoplasm, mitochondria or 
both. 
Fatty acids are activated prior to oxidation by reac- 
tions of the following form: 
Fatty acid + ATP + CoA + Fatty acyl COA + AMP + PPi (2) 
Acetate is activated to acetyl CoA in cytoplasm and 
mitochondria, butyrate is activated to butyryl CoA 
solely in mitochondria [24] while oleate is activated 
to oleyl CoA solely in cytoplasm [25]. It follows that 
injection of acetate would be expected to produce 
pyrophosphate in both cytoplasm and mitochondria; 
butyrate solely in mitochondria nd oleate solely in 
cytoplasm. Table 3 shows that butyrate or acetate 
raised total measured [~PPi] content about lo-times 
above control values; however, butyrate increased 
AMP content almost Stimes above control values 
while acetate raised AMP content only 2.5times. In 
contrast, oleate increased free cytoplasmic [PPi] but 
did not affect total PPi content or AMP levels. The 
difference between the effects of butyrate and oleate 
confirm that when oleate is activated, PP, is produced 
solely in cytoplasm. The higher AMP levels with buty- 
rate, in comparison with acetate, suggest either that 
K69 
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butyrate is activated more rapidly than acetate or that 
its activation is entirely mitochondrial while that of 
acetate occurs in both cytoplasm and mitochondria: 
this accords with the results of enzyme distribution 
studies, 
If it is accepted that butyrate injection and activa- 
tion leads to large production of AMP and PPi in the 
mitochondrial matrix then several problems arise 
because AMP cannot be carried out of mitochondria 
on the adenine nucleotide tratrslocator and myokinase 
is not present within mitochondria. The first question 
is: how does AMP get out of mitochondria during 
butyrate activation? The second is: why does PP, not 
accumulate in stoichiometric amounts equivalent to 
the AMP produced uring butyrate activation? 
As to the question of how AMP leaves mitochon- 
dria during its formation after acetate or butyrate 
activation, the fall in [cu-ketoglutarate] by 4-fold and 
the rise of [malate] by up to 4-fold suggests activa- 
tion of a-ketoglutarate d hydrogenase and succinic 
thiokinase, with consequent GTP formation. This 
pathway provides the mechanism for the intramito- 
chondrial conversion of AMP to ADP via the familiar 
pathway of substrate phosphorylation. Actual flux 
measurements will have to be made before this sug 
gestion can be confirmed. 
To turn to the second question: During butyrate 
metabolism, [AMP] increased from 0.2-0.9 pmol/g 
while [PPi] increased only from 0.014-0.12 pmol/g. 
This could be taken as evidence for an active pyrophos- 
phatase in mitochondrial matrix active in vivo. But 
the fact that butyrate, which should produce PPi only 
in mitochondria, also raised the calculated free cyto- 
plasmic [ZPPl] with all its attendant changes in the 
levels of glucose and of the entire sequence of glycol- 
ytic metabolites, trongly suggests hat PPi formed in 
the mitochondria can be exported to the cytoplasm. 
If this were not so, it would be difficult to explain 
how PPi formed in mitochondria is able to affect cyto- 
plasmic metabolites with which it is in apparent near- 
equilibrium. 
Injection of NaCl solutions in molar concentrations 
equivalent to the sodium butyrate or sodium acetate 
injections caused no changes inglucose content. There 
was a 40% increase in [glucose 6-phosphate] but a 
decrease in the calculated free cytoplasmic [PPi]. A 
comparison of tables 3 and 4 shows that any treatment 
which resulted in an increase in the concentration of 
liver glucose resulted in an increase in calculated free 
cytoplasmic [CPP,]. That free cytoplasmic [~PP,] is 
K70 
involved and not some other factor is indicated by 
the fact that oleate injection increased liver [glucose] 
and free [ZPPJ without changing the cytoplasmic 
[NAD’]/[NADH] ratio as would be expected if oleate 
were a major liver substrate. Inspite of all these metab- 
olite changes, the value for Keq. obtained in eq. (1) 
remained close to the value of 45.9 expected at equil- 
ibrium. 
These experiments demonstrate hat alteration of 
free cytoplasmic pyrophosphate concentration, either 
by direct administration of PPi or by administration 
of substrates which lead to pyrophosphate produc- 
tion, affects not only liver and blood glucose content, 
but also the content of the other substrates li ted in 
eq. (1). While the nature of the enzyme or enzymes 
catalyzing this reaction remain unknown, possible 
candidates suggested have been glucose 6-phosphatase 
[26,27] or alkaline phosphatase [28]. These enzymes 
are thought, however, to exist in compartments other 
than cytoplasm and to have kinetic constants in vitro 
which would not be compatible with the apparent 
rates required in vivo. 
An unexpected finding of this study was the appar- 
ent inverse relationship between an increase in total 
measured cellular pyrophosphate and a decrease inthe 
cytoplasmic phosphorylation potential. In all cases 
studied where total measured [pyrophosphate] was 
X.03 pmol/g wet wt (table 3), there was a decrease 
of 3-5fold in the calculated free cytoplasmic phos- 
phorylation potential or [ZATP]/[ZADP] [ZPi] ratio 
(table 4). Associated with this elevation in total mea- 
sured .[ XPPi] there was a decrease in [ct-ketoglutarate] 
and [glutamate] and an elevation of measured AMP 
content, and a decrease in the free cytoplasmic 
[NADP+]/ [NADPH] ratio. [Glutamate] and [cu-keto- 
glutarate] are in apparent near-equilibrium with the 
free mitochondrial [NAD+]/[NADH] [29], however, 
there appears to be no consistent change in the redox 
state of the pyridine nucleotides as a result of increas- 
ing mitochondrial pyrophosphate as judged by the 
[/_Lhydroxybutyrate] / [acetoacetate] ratio. The fall in 
a-ketoglutarate and glutamate, a decrease in the free 
cytoplasmic [NADP+] / [NADPH] ratio and a rise in 
liver glucose is also seen after glucagon administration 
in vivo [ 111. The similarity of effects of raising total 
PPi or of injecting glucagon raises questions about the 
mode of glucagon action. 
The free cytoplasmic [ZATP]/[ZADP] [ZPi] ratio 
was calculated from the reactants of the glyceraldehyde 
3-phosphate dehydrogenase and 3-phosphoglycerate 
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kinase reactions [4]. It is difficult to believe this sys- 
tem does not achieve near-equilibrium in liver, but 
why elevation of total liver PPi content should cause 
a decrease in this parameter isunclear. It is worth 
noting, however, that both butyrate and acetate injec- 
tion increase the total measured ADP 1.5-times in 
addition to increasing the measured AMP. In view of 
the insignificant change in calculated free cytoplasmic 
[ADP] (table 3), the increases inAMP and presumably 
in mitochondrial ADP suggest that a redistribution of 
adenine nucleotides occurs as a result of butyrate 
injection. The translocase cannot increase mitochon- 
drial adenine nucleotide since it requires acytoplasmic 
ADP. It is, of course, possible that mitochondria can 
undergo a net increase in adenine nucleotide by trans- 
porting ADP into mitochondria with Ca2+ [30]. 
This seems unlikely, however, under conditions of 
increased PPi since there should exist a reciprocal rela- 
tionship between free [Ca”] and free [ZPPi] since the 
solubility product of CazPPi s about 1.8 X lo-l3 M 
[3 11. In rats which have been starved for 72 h, buty- 
rate injection can raise total measured PP, to 
2.5 pmol/g wet wt. Assuming all of this PPi is in a 
mitochondrial matrix space of IO%, mitochondrial 
PPi would approach 25 mM. Under these conditions 
mitochondrial [Ca”‘] 28 X 10e6 M may exceed the 
solubility product of CazPPi. Since the solubility 
product of Mg2P207 is 1 X lo-r3-2 X 1O-‘5 M, at 
pH 11, similar effects with mitochondrial Mg2+ are 
even more likely. Information on the mitochondrial 
matrix free [Mg’+] is however, unavailable at present. 
Elevation of total or mitochondrial [PPi] to 
x.04 pmol/g, in addition to altering cytoplasmic 
[ZATP]/ [ZADP] [ZZPi], also changes the ‘[3-phospho- 
glycerate]/ [pyruvate] ratio from the range of l-3 
which is characteristic of the fed animal to 7-l 1 
(table 4) characteristic of the starved or streptozotocin 
diabetic or the glucagon-treated animal [21]. Thus 
while phosphate, pyrophosphate or glucose injection 
all raise the levels of glycolytic intermediates in the 
fed animal (table 2), pyrophosphate injection differed 
from the others in failing to increase [lactate] and 
[pyruvate] to the large extent seen after glucose or 
phosphate injection. The same effect is seen after ace- 
tate or butyrate injection, both of which raise total 
measured PPi. Again oleate which produced only cyto- 
plasmic PPi had no effect on the [3-phosphoglycerate]/ 
[pyruvate] ratio. Ca’+-dependent protein kinases 
which affect the phosphorylation of pyruvate kinase 
have been defined [32] but unless the free cytosolic 
[Ca”] is <lob8 M, it is difficult to reconcile a simul- 
taneous increase in both free [PPi] and free [Ca”‘]. It 
is known that Ca2+ isexported from isolated mito- 
chondria in response to oxidation of the mitochon- 
drial [NAD’]/[NADH] ratio [33]. There is, however, 
no correlation of this effect with oxidation of the 
mitochondrial [NAD’] / [NADH] as determined in 
vivo. There is a correlation of this effect with a 
decrease of cytosolic [I;ATP] / [LADPI [ ZPi], but 
Ca2+ export from mitochondria in response to a 
decrease in cytoplasmic [ZATP]/[ZADP] [CPi] has 
not been described. 
A more likely possibility would seem to be that 
Ca2’ could leave mitochondria fter butyrate or ace- 
tate injection as Ca,PPi and dissociate in cytosol where 
free [PPi] and free [Ca”‘] are lower. Alternatively, a
pyrophosphate:protein phosphotransferase [36] 
responsive to mitochondrial PPi should be considered. 
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